U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Organization
  4. Center for Drug Evaluation and Research (CDER)
  5. CDER Offices and Divisions
  6. Office of Neuroscience - Division of Psychiatry
  1. CDER Offices and Divisions

Office of Neuroscience - Division of Psychiatry

The Division of Psychiatry (DP) regulates and reviews Investigational New Drug (IND) applications and marketing applications for products for the treatment of psychiatric diseases and conditions, such as bipolar disorder, schizophrenia, schizoaffective disorder, major depressive disorder, attention deficit hyperactivity disorder, obsessive-compulsive disorder, panic attacks, posttraumatic stress disorder, generalized anxiety disorder, autism spectrum disorder, and insomnia.

Contact Us

Mailing Address

Food and Drug Administration
Center for Drug Evaluation and Research
Division of Psychiatry (DP)
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2260
Fax: (301) 796-9841

OND Office and Division Contact Information (PDF)

Resources For You



Back to Top